Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcomeRichard W Tothill, Anna V Tinker, Joshy George, et al.Blood Advances|December 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphomaSasanka M Handunnetti, Amit Khot, Piers Blombery, et al.Blood|October 26, 2023
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC studyAdrian Minson, Nada Hamad, Chan Y Cheah, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.Blood|April 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissionsSasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, et al.Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRichard L Piekarz, Robin Frye, Maria Turner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell LymphomaMark W Clemens, L Jeffrey Medeiros, Charles E Butler, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2021
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationshipL Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, et al.Pageof 6